Virtual substance use disorder (SUD) provider PursueCare netted $20 million in a series B fundraising round. The Middletown, Connecticut-based company also acquired three software-based digital therapeutics developed by Pear Therapeutics, which filed for bankruptcy in April 2023. Pear’s SUD–focused prescription digital therapeutic (PDT) reSET landed an FDA de novo in 2017. The products can be used as self-guided cognitive behavioral therapy (CBT) tools or integrated into a treatment plan. reSET is designed for general SUD, reSET-O for opioid use disorder (OUD) and reSET-A for alcohol use disorder (AUD).
Read the full article: Addiction Startup PursueCare Raises $20M, Acquires Pear Therapeutics’ Tech //
Source: https://bhbusiness.com/2023/12/13/addiction-startup-pursuecare-raises-20m-acquires-pear-therapeutics-tech